Cytotoxic Drug Treatment

Jul 24, 2018 by in MUSCULOSKELETAL MEDICINE Comments Off on Cytotoxic Drug Treatment

Chapter 46 Cytotoxic Drug Treatment Eva D. Papadimitraki, MD , Dimitrios T. Boumpas, MD, FACP INTRODUCTION Cytotoxic agents were initially introduced for their ability to interrupt nucleic acid and protein…

read more

Systemic Steroids

Jul 24, 2018 by in MUSCULOSKELETAL MEDICINE Comments Off on Systemic Steroids

Chapter 45 Systemic Steroids Mustafa Al-Maini, MD , Murray Urowitz, MD INTRODUCTION Corticosteroid medications are found in the therapeutic armamentarium of most medical specialties. Rheumatologists have had a long relationship…

read more

Overlap Syndromes, Mixed Connective Tissue Disease, and Undifferentiated Connective Tissue Disease

Jul 24, 2018 by in MUSCULOSKELETAL MEDICINE Comments Off on Overlap Syndromes, Mixed Connective Tissue Disease, and Undifferentiated Connective Tissue Disease

Chapter 38 Overlap Syndromes, Mixed Connective Tissue Disease, and Undifferentiated Connective Tissue Disease Robert W. Hoffman, DO INTRODUCTION Classification of the rheumatic diseases continues to be challenging for a number…

read more

Pregnancy

Jul 24, 2018 by in MUSCULOSKELETAL MEDICINE Comments Off on Pregnancy

Chapter 40 Pregnancy Megan E.B. Clowse, MD, MPH , Michelle Petri, MD, MPH INTRODUCTION As systemic lupus erythematosus (SLE) treatment has improved, more women with lupus are able to become…

read more

Antibodies to SSA/Ro and SSB/La: Potential Mechanisms of Tissue Injury in Neonatal Lupus-Congenital Heart Block

Jul 24, 2018 by in MUSCULOSKELETAL MEDICINE Comments Off on Antibodies to SSA/Ro and SSB/La: Potential Mechanisms of Tissue Injury in Neonatal Lupus-Congenital Heart Block

Chapter 22D Antibodies to SSA/Ro and SSB/La: Potential Mechanisms of Tissue Injury in Neonatal Lupus-Congenital Heart Block Jill P. Buyon, MD , Robert M. Clancy, PhD PATHOGENESIS: LAYING THE GROUNDWORK…

read more
Premium Wordpress Themes by UFO Themes